2,072
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Feasibility and acceptability of an integrated mind-body intervention for depression: whole-body hyperthermia (WBH) and cognitive behavioral therapy (CBT)

, , , , , , , , , , , , & show all
Article: 2351459 | Received 27 Dec 2023, Accepted 10 Apr 2024, Published online: 14 May 2024

References

  • World Health Organization. Health statistics and information systems: depression; 2021.
  • Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report. AJP. 2006;163(11):1–13. doi: 10.1176/appi.ajp.163.11.1905.
  • Li X, Frye MA, Shelton RC. Review of pharmacological treatment in mood disorders and future directions for drug development. Neuropsychopharmacology. 2012;37(1):77–101. doi: 10.1038/npp.2011.198.
  • Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Focus (Am Psychiatr Publ). 2018;16(4):420–429. doi: 10.1176/appi.focus.16407.
  • Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28–40. doi: 10.1176/appi.ajp.163.1.28.
  • Avery DH, Wildschiødtz G, Rafaelsen OJ. Nocturnal temperature in affective disorder. J Affect Disord. 1982;4(1):61–71. doi: 10.1016/0165-0327(82)90020-9.
  • Rausch JL, Johnson ME, Corley KM, et al. Depressed patients have higher body temperature: 5-HT transporter long promoter region effects. Neuropsychobiology. 2003;47(3):120–127. doi: 10.1159/000070579.
  • Song X, Zhang Z, Zhang R, et al. Predictive markers of depression in hypertension. Medicine (Baltimore). 2018;97(32):e11768. doi: 10.1097/MD.0000000000011768.
  • Raison CL, Hale MW, Williams LE, et al. Somatic influences on subjective well-being and affective disorders: the convergence of thermosensory and Central serotonergic systems. Front Psychol. 2015;5:1580. doi: 10.3389/fpsyg.2014.01580.
  • Avery DH, Shah SH, Eder DN, et al. Nocturnal sweating and temperature in depression. Acta Psychiatr Scand. 1999;100(4):295–301. doi: 10.1111/j.1600-0447.1999.tb10864.x.
  • Souetre E, Salvati E, Wehr TA, et al. Twenty-four-hour profiles of body temperature and plasma TSH in bipolar patients during depression and during remission and in normal control subjects. Am J Psychiatry. 1988;145(9):1133–1137. doi: 10.1176/ajp.145.9.1133.
  • Duncan WC.Jr, Circadian rhythms and the pharmacology of affective illness. Pharmacol Ther. 1996;71(3):253–312. doi: 10.1016/s0163-7258(96)00092-7.
  • Szuba MP, Guze BH, Baxter LR. Electroconvulsive therapy increases circadian amplitude and lowers core body temperature in depressed subjects. Biol Psychiatry. 1997;42(12):1130–1137. doi: 10.1016/s0006-3223(97)00046-2.
  • Hanusch K-U, Janssen CH, Billheimer D, et al. Whole-body hyperthermia for the treatment of major depression: associations with thermoregulatory cooling. Am J Psychiatry. 2013;170(7):802–804. doi: 10.1176/appi.ajp.2013.12111395.
  • Hanusch K-U, Janssen CW. The impact of whole-body hyperthermia interventions on mood and depression – are we ready for recommendations for clinical application? Int J Hyperthermia. 2019;36(1):573–581. doi: 10.1080/02656736.2019.1612103.
  • Lowry C, Flux M, Raison C. Whole-body heating: an emerging therapeutic approach to treatment of major depressive disorder. Focus (Am Psychiatr Publ). 2018;16(3):259–265. doi: 10.1176/appi.focus.20180009.
  • Aaland M. Sweat: the illustrated history and description of the Finnish sauna, Russian bania, Islamic hammam, Japanese mushi-buro, Mexican temescal, and American Indian & Eskimo sweat lodge. Santa Barbara (CA): Capra Press; 1978.
  • Janssen CW, Lowry CA, Mehl MR, et al. Whole-body hyperthermia for the treatment of major depressive disorder: a randomized clinical trial. JAMA Psychiatry. 2016;73(8):789–795. doi: 10.1001/jamapsychiatry.2016.1031.
  • Nyer M, Hopkins LB, Farabaugh A, et al. Community-delivered heated Hatha yoga as a treatment for depressive symptoms: an uncontrolled pilot study. J Altern Complement Med. 2019;25(8):814–823. doi: 10.1089/acm.2018.0365.
  • Cuijpers P, Cristea IA, Karyotaki E, et al. How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence. World Psychiatry. 2016;15(3):245–258. doi: 10.1002/wps.20346.
  • Cully JA, Dawson DB, Hamer J, et al. A provider’s guide to brief cognitive behavioral therapy. Houston (TX): Department of Veterans Affairs South Central MIRECC; 2020. https://www.mirecc.va.gov/visn16/docs/therapists_guide_to_brief_cbtmanual.pdf
  • Beck JS. Cognitive behavior therapy: basics and beyond. New York (NY): Guilford Press; 2020.
  • Kazantzis N, Clayton X, Cronin TJ, et al. The cognitive therapy scale and cognitive therapy scale-revised as measures of therapist competence in cognitive behavior therapy for depression: relations with short and long term outcome. Cogn Ther Res. 2018;42(4):385–397. doi: 10.1007/s10608-018-9919-4.
  • Blackburn I-M, James IA, Milne DL, et al. The revised cognitive therapy scale (CTS-R): psychometric properties. Behav Cogn Psychother. 2001;29(4):431–446. doi: 10.1017/S1352465801004040.
  • Cuijpers P, Karyotaki E, Weitz E, et al. The effects of psychotherapies for major depression in adults on remission, recovery and improvement: a meta-analysis. J Affect Disord. 2014;159:118–126. doi: 10.1016/j.jad.2014.02.026.
  • Mason AE, Fisher SM, Chowdhary A, et al. Feasibility and acceptability of a whole-body hyperthermia (WBH) protocol. Int J Hyperthermia. 2021;38(1):1529–1535. doi: 10.1080/02656736.2021.1991010.
  • First M, Williams J, Karg R, et al. Structured clinical interview for DSM 5-research version (SCID-5 for DSM-5, research version; SCID-5-RV). Arlington (VA): American Psychiatric Association; 2015.
  • Chambers CD. Risks of hyperthermia associated with hot tub or spa use by pregnant women. Birth Defects Res A Clin Mol Teratol. 2006;76(8):569–573. doi: 10.1002/bdra.20303.
  • Chandler GM, Iosifescu DV, Pollack MH, et al. Validation of the Massachusetts general hospital antidepressant treatment history questionnaire (ATRQ). CNS Neurosci Ther. 2010;16(5):322–325. doi: 10.1111/j.1755-5949.2009.00102.x.
  • Qualtrics XM - Experience Management Software. Qualtrics; 2022. https://www.qualtrics.com/
  • Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8(1):77–100. doi: 10.1016/0272-7358(88)90050-5.
  • Hengartner MP, Plöderl M. Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression. BMJ Evid Based Med. 2022;27(2):69–73. doi: 10.1136/bmjebm-2020-111600.
  • Button KS, Kounali D, Thomas L, et al. Minimal clinically important difference on the Beck Depression Inventory - II according to the patient’s perspective. Psychol Med. 2015;45(15):3269–3279. doi: 10.1017/S0033291715001270.
  • Cella D, Riley W, Stone A, et al. The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol. 2010;63(11):1179–1194. doi: 10.1016/j.jclinepi.2010.04.011.
  • Healthmeasures. net. https://www.healthmeasures.net/.
  • Kroenke K, Stump TE, Chen CX, et al. Minimally important differences and severity thresholds are estimated for the PROMIS depression scales from three randomized clinical trials. J Affect Disord. 2020;266:100–108. doi: 10.1016/j.jad.2020.01.101.
  • Cella D, Gershon R, Lai J-S, et al. The future of outcomes measurement: item banking, tailored short-forms, and computerized adaptive assessment. Qual Life Res. 2007;16 Suppl 1(S1):133–141. doi: 10.1007/s11136-007-9204-6.
  • Kendall PC, Howard BL, Hays RC. Self-referent speech and psychopathology: the balance of positive and negative thinking. Cogn Ther Res. 1989;13(6):583–598. doi: 10.1007/BF01176069.
  • Beck AT. The evolution of the cognitive model of depression and its neurobiological correlates. Am J Psychiatry. 2008;165(8):969–977. doi: 10.1176/appi.ajp.2008.08050721.
  • Beck AT. Cognitive therapy and the emotional disorders. New York (NY): Penguin; 1979.
  • Dennis JP, Vander Wal JS. The cognitive flexibility inventory: instrument development and estimates of reliability and validity. Cogn Ther Res. 2010;34(3):241–253. doi: 10.1007/s10608-009-9276-4.
  • Mayer JD, Gaschke YN. The experience and meta-experience of mood. J Pers Soc Psychol. 1988;55(1):102–111. doi: 10.1037/0022-3514.55.1.102.
  • Bender R, Lange S. Adjusting for multiple testing—when and how? J Clin Epidemiol. 2001;54(4):343–349. doi: 10.1016/s0895-4356(00)00314-0.
  • Persons JB, Burns DD. Mechanisms of action of cognitive therapy: the relative contributions of technical and interpersonal interventions. Cogn Ther Res. 1985;9(5):539–551. doi: 10.1007/BF01173007.
  • Health NCC, For M. Depression: management of depression in primary and secondary care. Lond Natl Inst Clin Excell. 2004;24.
  • O’Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol. Psychiatry. 2007;62(11):1208–1216. doi: 10.1016/j.biopsych.2007.01.018.